REVersal of nEuromusculAr bLocking Agents in Patients Undergoing General Anaesthesia (REVEAL Study).

Massimiliano Greco Pier Francesco CarusoGiovanni AngelottiRomina AcetoGiacomo CoppaliniNicolò MartinettiMarco AlbiniLori D BashMichele CarvelloFederico Piccioni Roberta MonzaniMarco MontorsiMaurizio Cecconi

Published in: Journal of clinical medicine (2023)

Unrestricted availability of sugammadex led to a considerable increase in pharmacological NMBA reversal, with rocuronium use also rising. More research is needed to determine how unrestricted and safer NMBA reversal affects anesthesia intraoperative monitoring and practice.

Keyphrases

patients undergoing
primary care
genome wide
gene expression
single cell
quality improvement